1-4 of 4
Alnawaz Rehemtulla
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Olaparib and Radiotherapy Induce Type I Interferon– and CD8+ T Cell–Dependent Sensitization to Immunotherapy in Pancreatic Cancer

Victoria M. Valvo, Qiang Zhang, Long Jiang, Erin A. Holcomb, Ashley N. Pearson, Anna G. Edmunds, Hailey G. Faulkner, Jadyn G. James, Akshay Tate, Amanda K. Huber, Zhuwen Wang, Yupei Guo, David Karnak, Leslie A. Parsels, Joshua D. Parsels, Yu L. Lei, Alnawaz Rehemtulla, Heng Lin, Eileen S. Carpenter, Daniel R. Wahl, Vaibhav Sahai, Theodore S. Lawrence, Michael D. Green, Meredith A. Morgan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther OF1–OF16.
https://doi.org/10.1158/1535-7163.MCT-24-0210
Published: 17 December 2024
View article titled, Olaparib and Radiotherapy Induce Type I Interferon– and CD8<sup>+</sup> T Cell–Dependent Sensitization to Immunotherapy in Pancreatic Cancer
Open the PDF for Olaparib and Radiotherapy Induce Type I Interferon– and CD8<sup>+</sup> T Cell–Dependent Sensitization to Immunotherapy in Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Cotargeting MAPK and PI3K Signaling with Concurrent Radiotherapy as a Strategy for the Treatment of Pancreatic Cancer

Terence M. Williams, Athena R. Flecha, Paul Keller, Ashwin Ram, David Karnak, Stefanie Galbán, Craig J. Galbán, Brian D. Ross, Theodore S. Lawrence, Alnawaz Rehemtulla, Judith Sebolt-Leopold
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (5): 1193–1202.
https://doi.org/10.1158/1535-7163.MCT-12-0098
Published: 08 May 2012
View article titled, Cotargeting MAPK and PI3K Signaling with Concurrent Radiotherapy as a Strategy for the Treatment of Pancreatic Cancer
Open the PDF for Cotargeting MAPK and PI3K Signaling with Concurrent Radiotherapy as a Strategy for the Treatment of Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

A Novel Kinase Inhibitor of FADD Phosphorylation Chemosensitizes through the Inhibition of NF-κB

Katrina A. Schinske, Shyam Nyati, Amjad P. Khan, Terence M. Williams, Timothy D. Johnson, Brian D. Ross, Ricardo Pérez Tomás, Alnawaz Rehemtulla
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (10): 1807–1817.
https://doi.org/10.1158/1535-7163.MCT-11-0362
Published: 09 October 2011
View article titled, A Novel Kinase Inhibitor of FADD Phosphorylation Chemosensitizes through the Inhibition of NF-κB
Open the PDF for A Novel Kinase Inhibitor of FADD Phosphorylation Chemosensitizes through the Inhibition of NF-κB in another window
Journal Articles

Evaluation of Cancer Therapy Using Diffusion Magnetic Resonance Imaging

Brian D. Ross, Bradford A. Moffat, Theodore S. Lawrence, Suresh K. Mukherji, Stephen S. Gebarski, Douglas J. Quint, Timothy D. Johnson, Larry Junck, Patricia L. Robertson, Karin M. Muraszko, Qian Dong, Charles R. Meyer, Peyton H. Bland, Patrick McConville, Hairong Geng, Alnawaz Rehemtulla, Thomas L. Chenevert
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2003) 2 (6): 581–587.
Published: 01 June 2003
View article titled, Evaluation of Cancer Therapy Using Diffusion Magnetic Resonance Imaging
Open the PDF for Evaluation of Cancer Therapy Using Diffusion Magnetic Resonance Imaging in another window